Search Results
Search for: epr |
512 results found
| # | Title | Type | Source | Description |
|---|---|---|---|---|
| 1 | Australia Launches Ambitious Circular Economy Framework to Double Circularity by 2035 | Regulatory Regions | gpcgateway.com | e approach, the framework provides a blueprint for aligning economic progress with |
| 2 | Brazil Opens Public Consultation on Regulation for Handmade Cosmetics | Regulatory Regions | gpcgateway.com | ion is an opportunity for citizens, entrepreneurs, and experts to help shape fair a |
| 3 | Brazil Launches Environmental Monitoring Strategy for PFOS and Pesticides | Regulatory Regions | gpcgateway.com | riculture in Brazil This initiative represents a significant step toward ensurin |
| 4 | Chile Introduces Landmark Regulation to Strengthen Agricultural Pesticide Management | Regulatory Regions | gpcgateway.com | ent programs. Resolution 243 Exenta represents a significant step forward in Chi |
| 5 | COFEPRIS Evaluates the Use of FDC Red No. 3 in Food Beverages and Pharmaceuticals | Regulatory Regions | gpcgateway.com | r Protection Against Sanitary Risks (COFEPRIS) is currently conducting a risk analy |
| 6 | EPA Releases Draft Risk Evaluations for Phthalates and Related Chemicals | Regulatory Regions | gpcgateway.com | ts include harm to the developing male reproductive system. Nine Ke |
| 7 | EPA Finalizes Risk Evaluation for Diisodecyl Phthalate DIDP | Regulatory Regions | gpcgateway.com | larly to unprotected female workers of reproductive age who use spray products such |
| 8 | Council of the EU Adopts its Position on Sixth Revision of the Carcinogens, Mutagens and Reprotoxic Substances Directive with New Exposure Limits | Regulatory Regions | gpcgateway.com | pdate of the Carcinogens, Mutagens and Reprotoxic Substances Directive (CMRD). The |
| 9 | Paraguay Regulates Hygiene Cosmetic and Perfume Products under Decree No. 2942 | Regulatory Regions | gpcgateway.com | carcinogenic, mutagenic, or toxic for reproduction (CMR) according to Internationa |
| 10 | Thailand Reviews Hazardous Substances Act Following Stakeholder Consultation | Regulatory Regions | gpcgateway.com | rdous Substance Committee, composed of representatives from nine ministries—inclu |
| 11 | EU - Key Regulatory Insights 2024 | Regulatory Regions | gpcgateway.com | methylbenzyl) peroxide in June for its reproductive toxicity, and triphenyl phospha |
| 12 | United Kingdom - Key Regulatory Insights 2024 | Regulatory Regions | gpcgateway.com | carcinogenic, mutagenic, or toxic for reproduction (CMR). This action is in line w |
| 13 | Ukraine - Key Regulatory Insights 2024 | Regulatory Regions | gpcgateway.com | that are carcinogenic, mutagenic, and reprotoxic (CMRs) or those harmful to aquati |
| 14 | Japan publishes J4CE 2024 case studies report showcasing circular economy initiatives | Regulatory Regions | gpcgateway.com | Extended Producer Responsibility (EPR) Policies These framewo |
| 15 | Regulatory Updates on Trisiloxane and Terpene Substances in Canada | Regulatory Regions | gpcgateway.com | fied concerns include carcinogenicity, reproductive toxicity, and effects on the ne |
| 16 | California’s OEHHA Adds New Toxicity Endpoint for Bisphenol S BPS in Proposition 65 List | Regulatory Regions | gpcgateway.com | for Bisphenol S (BPS) to include male reproductive toxicity, effective January 3, |
| 17 | EPA Opens Public Comment Period on Carbon Tetrachloride Risk Management Rule | Regulatory Regions | gpcgateway.com | tances Control Act (TSCA). This action represents the agency’s first step toward |
| 18 | UK HSE Publishes 2024 UK REACH Dossier and Substances Evaluation Reports | Regulatory Regions | gpcgateway.com | der GB CLP in 2025 to assess potential reproductive toxicity. |
| 19 | EU Launches Evaluation of Cosmetic Products Regulation: Call for Evidence Open Until 21 March | Regulatory Regions | gpcgateway.com | eking feedback from: Industry representatives (manufacturers, suppliers, S |
| 20 | Chile Strengthens Medical Device Regulations | Regulatory Regions | gpcgateway.com | ril 2023, gathered input from industry representatives and healthcare professionals |